Teva Pharmaceutical Industries Ltd.’s plan to reformulate or repurpose existing drugs will generate $3 billion of sales by 2020, part of a strategy to counter a decline in revenue from its best-selling Copaxone multiple sclerosis treatment.
You probably already saw the "60 Minutes" segment or promotional video for Amazon's new delivery service via unmanned aerial vehicles. Although it won't happen for several years, the e-commerce giant is already testing drones that have eight external propellers and a central unit that houses most of the electronic components. They look a lot like the devices hobbyists have been assembling for years or buying ready-made from toy stores and even Amazon itself.
Israeli Prime Minister Benjamin Netanyahu brought his campaign against the Iran agreement to Europe, saying in Rome yesterday sanctions intended to rein in the Islamic republic’s nuclear program are already crumbling.
In a year when Teva Pharmaceutical Industries Ltd. lost its chief executive officer, a patent ruling on its best-selling drug and analysts became the most bearish on the stock, the Israeli drugmaker is poised for the first gain since 2009.
Leaders of Israel’s 200,000 Bedouin Arab citizens called for civil disobedience against government efforts to resettle the traditionally nomadic population after weekend demonstrations erupted in violence.
Osem Investments Ltd. jumped to a record after Nestle SA, the world’s largest foodmaker, paid a premium to raise its stake in the Israeli food producer, stoking speculation it may seek a full takeover.